Finally, because of the cross-sectional nature of the present study we do not have the power to draw conclusions about the causal relationship between kisspeptin concentrations and insulin secretion or to speculate the contribution of kisspeptin to the defects observed in the context of overt type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.